Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Karyn E Yonekawa"'
Publikováno v:
Pediatric Nephrology ISBN: 9783642278433
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::69cfd0a7e53bd9c5fbc4149aaaa5ddfc
https://doi.org/10.1007/978-3-642-27843-3_126-1
https://doi.org/10.1007/978-3-642-27843-3_126-1
Autor:
Diane J. Nugent, Peggy Nakagawa, Karyn E Yonekawa, Rachelle C. Blain, Guy Young, Amy E. Lovejoy
Publikováno v:
Blood Coagulation & Fibrinolysis. 18:547-553
Bleeding is the major adverse reaction to anticoagulants, leading to significant morbidity and even mortality. Protamine is a specific antidote for heparin yet is only partially effective for enoxaparin, and the activated factor X inhibitor fondapari
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8531c616ee11db8bb486e5590415bbfb
https://doi.org/10.1097/mbc.0b013e328201c9a9
https://doi.org/10.1097/mbc.0b013e328201c9a9
Autor:
Amy E. Lovejoy, Karyn E Yonekawa, Guy Young, Peggy Nakagawa, Rachelle C. Blain, Diane J. Nugent
Publikováno v:
Blood Coagulation & Fibrinolysis. 18:97-103
New anticoagulants, including the direct thrombin inhibitors (DTIs) and fondaparinux, are increasingly replacing unfractionated heparin and enoxaparin. We examined the effects of argatroban (n = 60), bivalirudin (n = 44), heparin (n = 14), enoxaparin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b6136fdddafbcc6b21e6c253aa27797c
https://doi.org/10.1097/mbc.0b013e3280116c4c
https://doi.org/10.1097/mbc.0b013e3280116c4c
Publikováno v:
Perfusion. 19(5)
We investigated the anticoagulant effects of argatroban, a direct thrombin inhibitor, versus heparin in extracorporeal membrane oxygenation (ECMO) circuits. Three sham circuits were prepared according to our hospital’s standard practice and run for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b17eb3b25f3beee16cd7d59e74f34f67
https://pubmed.ncbi.nlm.nih.gov/15506032
https://pubmed.ncbi.nlm.nih.gov/15506032
Autor:
Diane J. Nugent, Amy E. Lovejoy, Peggy Nakagawa, Rachelle C. Blain, Guy Young, Karyn E Yonekawa
Publikováno v:
Blood. 104:1867-1867
BACKGROUND: The novel anticoagulants fondaparinux (Fond), argatroban (Arg), and bivalirudin (Biv) are being used increasingly for a variety of indications, even replacing heparin and warfarin in certain settings. While heparin and warfarin have antid
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7bb99a529bd0c34c3ce97ac9dfa7be30
https://doi.org/10.1182/blood.v104.11.1867.1867
https://doi.org/10.1182/blood.v104.11.1867.1867